Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07206745 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacterial Infections

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Oct 1, 2025 to Dec 1, 2025
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the clinical efficacy of a traditional Chinese medicine formula granule (Feireqing Granules) in the treatment of severe pneumonia caused by multidrug-resistant Gram-negative bacterial infections (MDR-GNB severe pneumonia), to establish a therapeutic regimen, and to generate high-quality clinical evidence.
Trial Details
NCT Number NCT07206745
Lead Sponsor Henan University of Traditional Chinese Medicine
Collaborators: Henan Provincial Hospital of TCM, Third Affiliated Hospital of Henan University of Traditional Chinese Medicine, Henan Provincial People's Hospital, The First Affiliated Hospital of Zhengzhou University, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Conditions
(from sponsor)		 Severe Pneumonia Caused by Multidrug-resistant Gram-negative Bacterial Infection
Related terms Pneumonia
Enrollment 152 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov